Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Operating Expenses | 1,476 | 2,023 | 3,720 | 2,400 | 839 |
| Operating Income | -1,476 | -2,023 | -3,720 | -2,400 | -839 |
| Interest Expense | 1 | 1 | 150 | 319 | 321 |
| Other Income | -1,308 | 1,335 | 980 | -294 | -403 |
| Pre-tax Income | -2,784 | -689 | -2,890 | -3,013 | -1,563 |
| Net Income Continuous | -2,784 | -689 | -2,890 | -3,013 | -1,563 |
| Net Income | $-2,784 | $-689 | $-2,890 | $-3,013 | $-1,563 |
| EPS Basic Total Ops | -3.90 | -0.90 | -109.91 | -112.91 | -2.70 |
| EPS Basic Continuous Ops | -3.77 | -0.97 | -109.89 | -112.80 | -2.76 |
| EPS Diluted Total Ops | -3.90 | -0.90 | -109.91 | -112.91 | -2.70 |
| EPS Diluted Continuous Ops | -3.77 | -0.97 | -109.89 | -112.80 | -2.76 |
| EBITDA(a) | $-1,476 | $-2,023 | $-3,599 | $-2,099 | $-537 |